Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 18,293 | 18,956 | 27,717 | 20,089 | 12,494 |
| Cost of Goods | 225 | N/A | N/A | N/A | N/A |
| Gross Profit | 18,068 | 18,956 | 27,717 | 20,089 | 12,494 |
| Operating Expenses | 60,778 | 40,302 | 62,650 | 57,110 | 46,365 |
| Operating Income | -42,485 | -21,346 | -34,933 | -37,021 | -33,871 |
| Interest Expense | 1,588 | 1,634 | 1,646 | 1,638 | 1,649 |
| Other Income | 530 | 545 | 564 | 547 | 637 |
| Pre-tax Income | -43,543 | -22,435 | -36,015 | -38,112 | -34,883 |
| Income Tax | -8,652 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -34,891 | -22,435 | -36,015 | -38,112 | -34,883 |
| Net Income | $-34,891 | $-22,435 | $-36,015 | $-38,112 | $-34,883 |
| EPS Basic Total Ops | -0.33 | -0.21 | -0.35 | -0.37 | -0.34 |
| EPS Basic Continuous Ops | -0.33 | -0.22 | -0.35 | -0.37 | -0.34 |
| EPS Diluted Total Ops | -0.33 | -0.21 | -0.35 | -0.37 | -0.34 |
| EPS Diluted Continuous Ops | -0.33 | -0.22 | -0.35 | -0.37 | -0.34 |
| EBITDA(a) | $-41,741 | $-20,700 | $-34,283 | $-36,380 | $-33,225 |